All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.

Image source: NPR
This story was curated by DOCFLiX.site from NPR as part of our daily briefing service. We select and present the most significant developments across Business, Technology, and Crime Scene to keep our readers informed with source-verified, primary-cited news coverage. The summary above is derived from the original reporting by NPR.